SAMN38856315
External Id
Sanofi
INSDC center name
2023-12-15T00:00:00Z
INSDC first public
2023-12-16T14:18:22.443Z
INSDC last update
SRS19877830
INSDC secondary accession
live
INSDC status
Human
NCBI submission model
Human.1.0
NCBI submission package
SRS19877830
SRA accession
53
age
HemaCare
biomaterial_provider
Erythroid differentiated CD34+ cells
cell_type
2018
collection_date
Clone_HD2_plate4-18
colony
Erythroid colonies from single clones were derived from plerixafor-mobilized HSC treated with Zinc Finger Nucleases targeting the BCL11A enhancer.
description
African American
ethnicity
USA
geo_loc_name
Healthy
health_state
ENR012
isolate
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Mobilized peripheral blood
tissue
Erythroid colony from a single clone derived from plerixafor mobilized HSC treated with BCL11A ZFN
title
BCL11A ZFN
treatment